(2020) GJB2-related hearing loss in central Iran: Review of the spectrum and frequency of gene mutations. Annals of Human Genetics. pp. 107-113. ISSN 0003-4800
Full text not available from this repository.
Abstract
Mutations in the GJB2 gene are a main cause of autosomal-recessive nonsyndromic hearing loss (ARNSHL) in many populations. Previous studies have estimated the average frequency of GJB2 mutations to be similar to 16 in Iran, but would vary among different ethnic groups. Here, we have taken together and reviewed results from our two previous publications and data from searching other published mutation reports to provide a comprehensive collection of data for GJB2 mutations and HL in central Iran. In all, 332 unrelated families were included and analyzed for the prevalence and type of the GJB2 gene mutations. In total, the frequency of GJB2 mutations was found to be 16 in the central provinces, which is significantly higher than those identified in southern populations of Iran. Also, c.35delG was the most frequent mutation in the related population. The present study suggests that mutations in the GJB2 gene, especially c.35delG, are important causes of HL in central Iran and can be used as a basis of genetic counseling and clinical guidelines in this region.
Item Type: | Article |
---|---|
Keywords: | clinical guidelines GJB2 Iranian population nonsyndromic hearing loss gjb2 mutations congenital deafness connexin-26 population prevalence update impairment families alleles pattern Genetics & Heredity |
Subjects: | QU Biochemistry. Cell Biology and Genetics > QU 300-560 Cell Biology and Genetics |
Divisions: | Faculty of Medicine > Department of Basic Science > Department of Medical Physics |
Page Range: | pp. 107-113 |
Journal or Publication Title: | Annals of Human Genetics |
Journal Index: | ISI |
Volume: | 84 |
Number: | 2 |
Identification Number: | https://doi.org/10.1111/ahg.12354 |
ISSN: | 0003-4800 |
Depositing User: | Zahra Otroj |
URI: | http://eprints.mui.ac.ir/id/eprint/11196 |
Actions (login required)
View Item |